Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05860296 |
| Title | Testing Experimental Anti-cancer Drug SLC-391 With an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | SignalChem Lifesciences Corporation |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Community Health Network | Indianapolis | Indiana | 46250 | United States | Details | |
| Horizon Verdi Oncology | Lafayette | Indiana | 47905 | United States | Details | |
| Karmanos Cancer Center | Detroit | Michigan | 48201 | United States | Details | |
| Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | United States | Details | |
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Cross Cancer Institute | Edmonton | Alberta | Canada | Details | ||
| Juravinski Cancer Centre | Hamilton | Ontario | Canada | Details | ||
| London Regional Cancer Centre | London | Ontario | Canada | Details | ||
| Sunnybrook Health Sciences Centre | Toronto | Ontario | Canada | Details | ||
| Jewish General Hospital | Montreal | Quebec | H3T 1E2 | Canada | Details | |
| McGill University Health Centre | Montreal | Quebec | H4A 3J1 | Canada | Details |